Blinatumomab, also known as Anatumomab, is a bispecific monoclonal antibody designed to simultaneously engage two distinct epitopes: CD3E on T cells and CD19 on B cells. This unique dual-binding capability facilitates the redirection of T cells to target and eliminate CD19-expressing B cells. Blinatumomab is primarily utilized in research focused on the treatment and understanding of acute lymphoblastic leukemia (ALL), offering significant insights into therapeutic strategies and disease management.
Blinatumomab, also known as Anatumomab, is a bispecific monoclonal antibody designed to simultaneously engage two distinct epitopes: CD3E on T cells and CD19 on B cells. This unique dual-binding capability facilitates the redirection of T cells to target and eliminate CD19-expressing B cells. Blinatumomab is primarily utilized in research focused on the treatment and understanding of acute lymphoblastic leukemia (ALL), offering significant insights into therapeutic strategies and disease management.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
